BioCentury
ARTICLE | Clinical News

NMP22 BladderChek Test regulatory update

July 18, 2005 7:00 AM UTC

MZT received Japanese marketing approval for NMP22 BladderCheck test, an assay to detect nuclear matrix protein NMP22 in urine, to diagnose bladder cancer. BladderChek is approved in the U.S., Europe ...